| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/16/2002 | WO2002000218A3 Methods of treating neutrophil-related diseases with topical anesthetics |
| 05/16/2002 | WO2002000164A8 Chemosensitizer |
| 05/16/2002 | WO2001098291A3 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 05/16/2002 | WO2001098290A3 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/16/2002 | WO2001097851A3 Compositions and methods to improve the oral absorption of antimicrobial agents |
| 05/16/2002 | WO2001097792A3 Neuraminidase inhibitors in the treatment of equine influenza virus infection |
| 05/16/2002 | WO2001097790A3 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 05/16/2002 | WO2001097789A3 Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase i and ii inhibitors |
| 05/16/2002 | WO2001096295A3 2-cyanopyrrolidine derivatives and their use as medicaments |
| 05/16/2002 | WO2001095890A3 Oral pharmaceutical compositions containing terbinafine |
| 05/16/2002 | WO2001089514A3 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent |
| 05/16/2002 | WO2001089511A3 Superficial therapeutic system containing o-acetylsalicylic acid, for treating skin pain |
| 05/16/2002 | WO2001088098A3 Fertilization of aged oocytes |
| 05/16/2002 | WO2001087335A3 Method for selectively inhibiting ghrelin action |
| 05/16/2002 | WO2001087308B1 Treatment of fibromyalgia and chronic fatigue syndrome |
| 05/16/2002 | WO2001087289A3 Propofol for treatment of sepsis |
| 05/16/2002 | WO2001087287A3 Use of pyrazole derivatives for treating infertility |
| 05/16/2002 | WO2001087038A3 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE |
| 05/16/2002 | WO2001085144A3 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 05/16/2002 | WO2001083478A3 Hydantoin-containing glucokinase activators |
| 05/16/2002 | WO2001083465A3 Alkynyl phenyl heteroaromatic glucokinase activators |
| 05/16/2002 | WO2001082912A3 TREATMENT OF PATHOLOGICAL CONDITIONS INFLUENCED BY THE ACTION OF MATRIX METALLOPROTEINASES (MMPs) USING PHANQUINONE |
| 05/16/2002 | WO2001081622A8 Diagnosis of diseases associated with dna repair |
| 05/16/2002 | WO2001081599A3 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 05/16/2002 | WO2001081319A3 Ultrashort acting hypnotic barbiturates |
| 05/16/2002 | WO2001080810A3 Chondroitin synthase gene and methods of making and using same |
| 05/16/2002 | WO2001079198A9 Pyrazoles for inhibiting protein kinase |
| 05/16/2002 | WO2001079155A3 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
| 05/16/2002 | WO2001076638A3 Compositions for drug delivery |
| 05/16/2002 | WO2001076597A3 A method of administering an antitumour compound using a polymer-camptothecin conjugate |
| 05/16/2002 | WO2001076578A8 Treatment of icu-associated hypocalcemia with vitamin d compounds |
| 05/16/2002 | WO2001074364A3 A use of galantamine for the treatment of alzheimer's disease; targeting the underlying cause of the disease |
| 05/16/2002 | WO2001074347A8 Method for reducing adverse effects of a weight loss regimen |
| 05/16/2002 | WO2001074341A3 Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant |
| 05/16/2002 | WO2001072292A3 Vitamin d compounds used to stabilize kidney transplants |
| 05/16/2002 | WO2001070953A3 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment |
| 05/16/2002 | WO2001070662A3 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 05/16/2002 | WO2001068143A3 Immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001068040A3 The use of plant extracts and sugars to protect keratinous tissue |
| 05/16/2002 | WO2001066100A3 Pharmaceutical composition |
| 05/16/2002 | WO2001062668A3 Sulfur containing compounds |
| 05/16/2002 | WO2001058434A3 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
| 05/16/2002 | WO2001054736A3 Compositions treated to inactivate infectious proteins |
| 05/16/2002 | WO2001054676A3 Formulations for states of dehydration |
| 05/16/2002 | WO2001049654A3 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 05/16/2002 | WO2001048163A3 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 05/16/2002 | WO2001047928A3 Imidazo 1,3,5 triazinones and the use thereof |
| 05/16/2002 | WO2001046180A3 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 05/16/2002 | WO2001045664A3 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 05/16/2002 | WO2001045663A3 USE OF AROMATIC POLYCYCLIC COMPOUNDS AS ACTIVATORS OF PPARs-TYPE RECEPTORS IN A COSMETIC OR PHARMACEUTICAL COMPOSITION |
| 05/16/2002 | WO2001040521A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/16/2002 | WO2001039747A3 Cassette-shaped constructional units in a rotary printing machine |
| 05/16/2002 | WO2001034636A9 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/16/2002 | WO2001032885A9 Human lipase |
| 05/16/2002 | WO2001032685A8 Gene expression directed by a super-psa promoter |
| 05/16/2002 | WO2001032128A9 Human chemokine beta-13 |
| 05/16/2002 | WO2001032125A3 Apparatus and process for preparing crystalline particles |
| 05/16/2002 | WO2001025408A9 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof |
| 05/16/2002 | WO2001007434A3 Indole derivatives and their use as 5ht2a ligands |
| 05/16/2002 | US20020058926 Synchronising of animal oestrus and intra vaginal devices useful therein |
| 05/16/2002 | US20020058839 Methods and compositions for modulating alpha adrenergic receptor activity |
| 05/16/2002 | US20020058838 Substituted benzenesulfonylureas and -thioureas-processes for their preparation and their use as pharmaceuticals |
| 05/16/2002 | US20020058817 For cancer therapy |
| 05/16/2002 | US20020058813 Spiro-indolines as Y5 receptor antagonists |
| 05/16/2002 | US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis |
| 05/16/2002 | US20020058804 Includes an active therapeutic agent joined to a blocking moiety sensitive to the catalytic action of molecules having retro- aldol and retro-Michael catalytic activity; antitumor; anticarcinogenic agents |
| 05/16/2002 | US20020058803 Preparing preferential compound; incubate sugar with activating agent, couple activated sugar with preferential compound, recover compound |
| 05/16/2002 | US20020058785 Novel lipopeptides as antibacterial agents |
| 05/16/2002 | US20020058712 Treatment of fibromyalgia with ubiquinone 10 and succinic acid |
| 05/16/2002 | US20020058710 For therapy and prophylaxis of arrhythmias, cardiac infraction, ischemic conditions, angina pectoris, shock, for preserving and storing a transplant for surgical measure |
| 05/16/2002 | US20020058709 For therapy and prophylaxis of allergic disease of the eye, nose, skin, ear, gastrointestinal tract or lungs |
| 05/16/2002 | US20020058708 Compositions containing hypotriglyceridemically active stilbenoids |
| 05/16/2002 | US20020058706 Method for treating asthma using pregabalin |
| 05/16/2002 | US20020058705 For use in therapy of hypercholesterolemia, as anti- ischemic and/or anti-thrombotic agent, as antiplatelet agent, or as agent against gastric ulcers induced by compounds, agents or drugs |
| 05/16/2002 | US20020058704 Multicomponent compositions containing chitosan and methods of preparing same |
| 05/16/2002 | US20020058701 Compositions containing hypoglycemically active stilbenoids |
| 05/16/2002 | US20020058700 Ion channel modulating agents |
| 05/16/2002 | US20020058699 Administering compound that reduces mitogen-activated protein kinase (MAPK) activity in neurons of the individual for reducing or inhibiting excessive neuronal excitability |
| 05/16/2002 | US20020058696 Chelate compound-containing antibacterial agent for helicobacter pylori |
| 05/16/2002 | US20020058695 Administering a bioavailability increasing effective amount of tetrahydropiperine, or an analog or derivative together with or proximate the administration of the nutrient or drug or other organic compound |
| 05/16/2002 | US20020058694 Ureido and thioureido derivatives of 4-amino-2(5H)-furanones and 4-amino-2(5H)-thiophenones as antitumor agents |
| 05/16/2002 | US20020058693 For prophylaxis and therapy of itching derived from contact dermatitis, allergic conjunctivitis, urticaria, atopic dermatitis |
| 05/16/2002 | US20020058692 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 05/16/2002 | US20020058691 For use in therapy of pain, arthritis, fever |
| 05/16/2002 | US20020058690 For therapy and prophylaxis of inflammatory disease susceptible to treatment with a non- steroidal anti-inflammatory agent |
| 05/16/2002 | US20020058689 Process for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b] [1, 4]diazepino[6, 7, 1-hi]indole derivatives |
| 05/16/2002 | US20020058688 Method of using cyclooxegenase-2 inhibitors in the treatment and prevention of dementia |
| 05/16/2002 | US20020058687 For therapy and prohylaxis of inflammatory diseases including joint inflammation, Crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (COPD) including asthma, chronic bronchitis |
| 05/16/2002 | US20020058686 Administering of angiotensin II receptor antagonist for therapy of angina |
| 05/16/2002 | US20020058685 Hydantoin derivative compounds, pharmace utical compositions, and methods of using same |
| 05/16/2002 | US20020058683 Oral combination of lufenuron and nitenpyram against fleas |
| 05/16/2002 | US20020058682 Administering to a candidate subject in need of such treatment, a thus-effective amount of at least one inhibitor of at least one calcium channel for loosening/slackening and/or relaxing cutaneous and/or subcutaneous human skin |
| 05/16/2002 | US20020058681 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 05/16/2002 | US20020058680 Indolecarboxylic compounds for treating seborrhea and complications thereof |
| 05/16/2002 | US20020058678 For therapy of diseases or pathological conditions involving inflammation such as chronic inflammatory diseases |
| 05/16/2002 | US20020058675 Therapy of psychosis in a human comprising administering (R)-hydroxynefazodone or a pharmaceutically acceptable salt |
| 05/16/2002 | US20020058674 Used for therapy of conditions associated with mucosal surfaces such as cervical dysphasia and cervical intraepithelial neoplasia |
| 05/16/2002 | US20020058673 Oral dosage form of an opioid analgesic which is subject to less abuse potential via the oral route than prior commercially available dosage forms |
| 05/16/2002 | US20020058672 Use of benzoylalkyl-1,2,3,6-tetrahydropyridines |
| 05/16/2002 | US20020058669 Process for the treatment of organophosphate poisoning |